A
44
4
PAYX
53
2
MCHP
54
4
NVDA
55
3
MA
60
3
NFLX
62
3
MLM
73
6
MPC
54
2
AMGN
47
6
WAT
54
6
HST
55
5
VMC
72
4
TSCO
48
2
MSFT
60
3
ALLE
32
2
LOW
58
2
V
70
4
PM
66
23
GOOGL
66
2
SCHW
61
3
A
44
4
PAYX
53
2
MCHP
54
4
NVDA
55
3
MA
60
3
NFLX
62
3
MLM
73
6
MPC
54
2
AMGN
47
6
WAT
54
6
HST
55
5
VMC
72
4
TSCO
48
2
MSFT
60
3
ALLE
32
2
LOW
58
2
V
70
4
PM
66
23
GOOGL
66
2
SCHW
61
3
Financhill
Back

Seres Therapeutics 10K Form

Sell
35

MCRB
Seres Therapeutics

Last Price:
0.72
Seasonality Move:
-11.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MCRB News And Ratings

See the #1 stock for the next 7 days that we like better than MCRB

MCRB Financial Statistics

Sales & Book Value

Annual Sales: $126.33M
Cash Flow: $-48.38M
Price / Cash Flow: 0
Annual Sales: $-0.33
Price / Book: 0

Profitability

EPS (TTM): -0.90000
Net Income (TTM): $-113.72M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -32.46%

Seres Therapeutics Earnings Forecast

Key Seres Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for MCRB have been equal to 69.46% of Gross Profit Margin.
  • The Research & Development expenses have been 115.46% of Revenue.
  • The Interest Expense is -11.59% of Operating Income.
  • The Net Earning history of MCRB is -90.02% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Seres Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MCRB
CUSIP: 81750R
Website: serestherapeutics.com

Debt

Debt-to-Equity Ratio: -2.26
Current Ratio: 1.78
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MCRB Technical Analysis vs Fundamental Analysis

Sell
35
Seres Therapeutics (MCRB) is a Sell

Is Seres Therapeutics a Buy or a Sell?